Description

Sulfaquinoxaline Sodium is the sodium salt form of the synthetic antibacterial agent sulfaquinoxaline. This compound is a critical active pharmaceutical ingredient (API) primarily valued for its potent antibacterial and anticoccidial properties. It is an essential component in veterinary medicine, specifically formulated for the prevention and treatment of coccidiosis and other bacterial infections in livestock and poultry. Professional buyers in the animal health and pharmaceutical manufacturing sectors rely on this API for producing effective therapeutic solutions.

Application

• Veterinary Pharmaceutical API: Primary active ingredient in injectable and oral formulations for livestock and poultry.
• Coccidiostat for Poultry: Prevention and treatment of intestinal coccidiosis caused by *Eimeria* species in chickens and turkeys.
• Broad-Spectrum Antibacterial Agent: Used against susceptible Gram-positive and Gram-negative bacteria in veterinary settings.
• Medicated Feed Premixes: Incorporated into feed additives for prophylactic herd health management.
• Aquaculture Therapeutics: Treatment of bacterial diseases in farmed fish under veterinary guidance.
• Companion Animal Medicine: Formulated for specific antibacterial therapies in dogs and cats.
• Research & Development: Used as a reference standard and in pharmacological studies within animal health R&D.

Basic Information

Product Name	Sulfaquinoxaline Sodium
CAS No.	967-80-6
Molecular Formula	C14H11N4NaO2S
Molecular Weight	322.32 g/mol
Synonyms	Sulfaquinoxaline Sodium Salt; Sodium Sulfaquinoxaline; N1-(2-Quinoxalinyl)sulfanilamide Sodium Salt; Sulfaquinoxaline Sodium Monohydrate; SQ-Na; Sulfaquinoxalinum Natricum; Benzo[g]quinoxaline-2-sulfonamide, N1-(4-amino- phenyl)-, sodium salt
EINECS	213-536-1

Quality Control

Our Sulfaquinoxaline Sodium is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing to ensure it meets high-purity pharmacopeial standards suitable for API use. A detailed Certificate of Analysis (COA) is provided with every shipment, documenting critical parameters including assay, related substances, residual solvents, and microbiological quality. Our quality commitment supports compliance with GMP principles for active pharmaceutical ingredients.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed after opening to prevent moisture absorption, which can affect stability and potency. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to slightly yellow crystalline powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	98.0% - 102.0% (on anhydrous basis)
Water Content (KF)	≤ 5.0%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any individual impurity ≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm
Microbiological Enumeration	Total aerobic microbial count ≤ 1000 cfu/g Total combined yeasts/molds ≤ 100 cfu/g
Specified Pathogens	Absent (per 1g for *E. coli* and *Salmonella*)

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.